Effectiveness and Safety of Silodosin in the Treatment of Benign Prostatic Hyperplasia
Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to confirm in a larger population in Europe the effectiveness
and safety observed with silodosin in previous clinical trials.
Phase:
Phase 4
Details
Lead Sponsor:
RECORDATI GROUP Recordati Industria Chimica e Farmaceutica S.p.A.